Previous close | 7.40 |
Open | 7.40 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1400 |
Day's range | 6.66 - 7.59 |
52-week range | 4.77 - 23.97 |
Volume | |
Avg. volume | 758,779 |
Market cap | 2.508B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.07 |
Earnings date | 09 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 10.00 |
At this time, I would like to welcome everyone to the LifeStance Health second quarter 2022 earnings call. Joining me today are Mike Lester, chief executive officer; Danish Qureshi, chief operating officer; and Mike Bruff, chief financial officer.
LifeStance Health (LFST) delivered earnings and revenue surprises of -58.33% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
LifeStance Health (LFST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.